These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 16247167

  • 1. CT evaluation of gastrointestinal stromal tumors treated with imatinib mesylate.
    Erturk SM.
    AJR Am J Roentgenol; 2005 Nov; 185(5):1366; author reply 1366-7. PubMed ID: 16247167
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Gastrointestinal stromal tumor with metastases in an adult woman treated with imatinib mesylate: MDCT findings.
    Busalacchi PJ, de la Calle MA, Torroba A, Del Río ST.
    AJR Am J Roentgenol; 2005 Mar; 184(3 Suppl):S58-61. PubMed ID: 15728023
    [No Abstract] [Full Text] [Related]

  • 4. CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings.
    Choi H, Charnsangavej C, de Castro Faria S, Tamm EP, Benjamin RS, Johnson MM, Macapinlac HA, Podoloff DA.
    AJR Am J Roentgenol; 2004 Dec; 183(6):1619-28. PubMed ID: 15547201
    [Abstract] [Full Text] [Related]

  • 5. Response evaluation of gastrointestinal stromal tumors.
    Choi H.
    Oncologist; 2008 Dec; 13 Suppl 2():4-7. PubMed ID: 18434631
    [Abstract] [Full Text] [Related]

  • 6. Imaging of gastrointestinal stromal tumors before and after imatinib mesylate therapy.
    Shankar S, Dundamadappa SK, Karam AR, Stay RM, van Sonnenberg E.
    Acta Radiol; 2009 Oct; 50(8):837-44. PubMed ID: 19735005
    [Abstract] [Full Text] [Related]

  • 7. Resistance to treatment in gastrointestinal stromal tumours: what radiologists should know.
    Tirumani SH, Jagannathan JP, Hornick JL, Ramaiya NH.
    Clin Radiol; 2013 Aug; 68(8):e429-37. PubMed ID: 23622797
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria.
    Choi H, Charnsangavej C, Faria SC, Macapinlac HA, Burgess MA, Patel SR, Chen LL, Podoloff DA, Benjamin RS.
    J Clin Oncol; 2007 May 01; 25(13):1753-9. PubMed ID: 17470865
    [Abstract] [Full Text] [Related]

  • 12. Very early detection of response to imatinib mesylate therapy of gastrointestinal stromal tumours using 18fluoro-deoxyglucose-positron emission tomography.
    Heinicke T, Wardelmann E, Sauerbruch T, Tschampa HJ, Glasmacher A, Palmedo H.
    Anticancer Res; 2005 May 01; 25(6C):4591-4. PubMed ID: 16334147
    [Abstract] [Full Text] [Related]

  • 13. [FDG-PET and CT in gastrointestinal stromal tumor treated with imatinib].
    Eigtved AI, Berthelsen AK, Kinnander C, Krarup-Hansen A.
    Ugeskr Laeger; 2003 Sep 08; 165(37):3507-9. PubMed ID: 14531350
    [Abstract] [Full Text] [Related]

  • 14. [Utility of FDG-PET for early evaluation of efficiency of imatinib mesylate (Glivec) in the treatment of gastrointestinal stromal tumors].
    García-González J, Sánchez Salmón A, Areses Manrique C, León Mateos L, Barandela Salgado J, López López R.
    Rev Esp Med Nucl; 2007 Sep 08; 26(2):100-2. PubMed ID: 17386236
    [Abstract] [Full Text] [Related]

  • 15. Sonography of multifocal Brucella orchitis.
    Domachevsky L, Peled N, Barzilai M.
    Ultraschall Med; 2008 Dec 08; 29 Suppl 5():275-6. PubMed ID: 19085749
    [No Abstract] [Full Text] [Related]

  • 16. Early detection of response to imatinib therapy for gastrointestinal stromal tumor by using 18F-FDG-positron emission tomography and computed tomography imaging.
    Zincirkeser S, Sevinc A, Kalender ME, Camci C.
    World J Gastroenterol; 2007 Apr 21; 13(15):2261-2. PubMed ID: 17465516
    [Abstract] [Full Text] [Related]

  • 17. MDCT appearance of gastrointestinal stromal tumors after therapy with imatinib mesylate.
    Warakaulle DR, Gleeson F.
    AJR Am J Roentgenol; 2006 Feb 21; 186(2):510-5. PubMed ID: 16423961
    [Abstract] [Full Text] [Related]

  • 18. Patterns of extension of gastrointestinal stromal tumors (GIST) treated with imatinib (Gleevec®) by 18F-FDG PET/CT.
    Valls-Ferrusola E, García-Garzón JR, Ponce-López A, Soler-Peter M, Fuertes-Cabero S, Moragas-Solanes M, Riera-Gil E, Carrió-Gasset I, Lomeña-Caballero F.
    Rev Esp Enferm Dig; 2012 Jul 21; 104(7):360-6. PubMed ID: 22849497
    [Abstract] [Full Text] [Related]

  • 19. Multimodal functional imaging for early response assessment in GIST patients treated with imatinib.
    Revheim ME, Hole KH, Bruland OS, Reitan E, Bjerkehagen B, Julsrud L, Seierstad T.
    Acta Oncol; 2014 Jan 21; 53(1):143-8. PubMed ID: 23710697
    [No Abstract] [Full Text] [Related]

  • 20. [Chinese consensus in diagnosis and treatment of gastrointestinal stromal tumor].
    Chinese Diagnosis and Treatment Experts Group for Gastrointestinal Stromal Tumors.
    Zhonghua Bing Li Xue Za Zhi; 2009 Oct 21; 38(10):697-702. PubMed ID: 20078976
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.